Results
|
101.
|
|
|
102.
|
|
|
103.
|
|
|
104.
|
|
|
105.
|
|
|
106.
|
|
|
107.
|
|
|
108.
|
|
|
109.
|
|
|
110.
|
|
|
111.
|
|
|
112.
|
|
|
113.
|
|
|
114.
|
|
|
115.
|
Antimitochondrial (pyruvate dehydrogenase) autoantibodies in autoimmune rheumatic diseases. [electronic resource] by
- Zurgil, N
- Bakimer, R
- Moutsopoulos, H M
- Tzioufas, A G
- Youinou, P
- Isenberg, D A
- Scheinberg, M
- Kveder, T
- Rozman, B
- Luderschmidt, C
Producer: 19921029
In:
Journal of clinical immunology vol. 12
Availability: No items available.
|
|
116.
|
A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosus. [electronic resource] by
- Doria, A
- Bass, D
- Schwarting, A
- Hammer, A
- Gordon, D
- Scheinberg, M
- Fox, N L
- Groark, J
- Stohl, W
- Kleoudis, C
- Roth, D
Producer: 20181211
In:
Lupus vol. 27
Availability: No items available.
|
|
117.
|
Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus. [electronic resource] by
- Doria, A
- Stohl, W
- Schwarting, A
- Okada, M
- Scheinberg, M
- van Vollenhoven, R
- Hammer, A E
- Groark, J
- Bass, D
- Fox, N L
- Roth, D
- Gordon, D
Producer: 20190722
In:
Arthritis & rheumatology (Hoboken, N.J.) vol. 70
Availability: No items available.
|